
Gemprime M 1mg/500mg Tablet SR
Marketer
Crassula Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Gemprime M 1mg/500mg Tablet SR
Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Commonly, Diabex Duo can cause hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with a fast-acting sugar source (e.g., glucose tablets, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before using Diabex Duo if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Gemprime M 1mg/500mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Gemprime M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gemprime M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gemprime M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with food.
Common Side effects of Gemprime M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Gemprime M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Gemprime M 1mg/500mg SR Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Gemprime M 1mg/500mg Tablet SR works:
Gemprime M 1mg/500mg Extended-Release tablets combine the anti-diabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Gemprime M 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Gemprime M 1mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release Gemprime M 1mg/500mg tablets are contraindicated during lactation due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gemprime M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gemprime M 1mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Gemprime M 1mg/500mg SR tablets cautiously, potentially requiring dose modification. Physician consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, the medication is unsuitable for patients exhibiting severe hepatic dysfunction.
What if you forget to take Gemprime M 1mg/500mg Tablet SR :
Should you forget a dose of Gemprime M 1mg/500mg sustained-release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gemprime M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
